[ad_1]
NEW YORK, Feb. 08, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Bright Health Group, Inc. (“Bright Health”, or the “Company”) (NYSE:BHG) and one of its officers. The class action, filed in United States District Court for the Eastern District of New York, and docketed under 22-cv-00101, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired: (a) Bright Health common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering conducted on or about June 24, 2021 (the “IPO” or “Offering”) ; and/or (b) Bright Health securities between June 24, 2021 and November 10, 2021, both dates inclusive (the “Class Period”). Plaintiff pursues claims against the Defendants under the Securities Act of 1933 (the “Securities Act” ) and the Securities Exchange Act of 1934 (the “Exchange Act”).
If you are a shareholder who purchased (a) Bright Health common stock pursuant and or traceable to the Offering or IPO, or (b) Bright Health securities during the class period, you have until March 7, 2022 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
[Clickhereforinformationaboutjoining[Clickhereforinformationaboutjoining
Full story available on Benzinga.com
[ad_2]
Source link
